In the past decades, numerous natural compounds with inhibitory effects on protein kinases have been identified or developed and some of them have been approved by the Federal Administration Agency (FDA) in the United States and used successfully in the treatment of human cancers clinically. The gene discussed is WEE1; the disease is cancer.